https://technical.ly/baltimore/wp-content/themes/national PGDx test gets 'Breakthrough Device' designation - Technical.ly Baltimore

Sciences

Jul. 30, 2018 11:18 am

PGDx test gets ‘Breakthrough Device’ designation

A liquid biopsy test made by the Baltimore-based company received the status.

Pipettes and test tubes.

(Photo by Flickr user Luca Volpi, used under a Creative Commons license)

Baltimore-based Personal Genome Diagnostics (PGDx) recently received a designation from federal regulators that’s designed to help allow patients to get quicker access to new devices.

The U.S. Food and Drug Administration’s Center for Devices and Radiological Health granted a “Breakthrough Device” designation for one of the Johns Hopkins spinout’s new kinds of cancer tests, which combine genomic analysis and the use of algorithms to analyze data.

Known as PGDx elio plasma resolve, the test is a liquid biopsy, a new form of genomic testing which allows a sample to be taken for analysis without requiring surgery. Along with the materials to run a test, the product includes a server and software for data analysis, said PGDx Senior Marketing Manager KC McGrath.

The Breakthrough Device designation is designed to expedite regulatory approval of a medical device that provides a more effective treatment or diagnoses for a debilitating disease or condition. The PGDx was selected based on results that showed it may help patients who cannot provide tissue samples. A feature of the test could also help select patients for certain therapies.

If approved, the company indicated it could be the first liquid biopsy test that can be “kitted” and run in laboratories.

Being granted the status “shows there is an unmet clinical need that PGDx elio plasma resolve can help address, and we’re excited about the opportunity to impact more patients globally by enabling this test to be run locally,” McGrath said.

Canton-based PGDx closed on $75 million in Series B funding earlier this year, and opened a second location in Brewers Hill.

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

PGDx signs a pair of partnerships as it looks to expand ‘kitted’ cancer tests

JHU spinout WindMIL Therapeutics expands to Philly, adds two new executives

Baltimore biotech company partners with JuiceBot on food safety

SPONSORED

Baltimore

Why a modern office matters for Asymmetrik’s growing culture

Baltimore, MD

SmartLogic

Developer

Apply Now
Baltimore, MD 21201

Agora Financial, an Agora Company

Front End Web Developer

Apply Now
Baltimore, MD 21201

Agora Financial

Email Deliverability Specialist

Apply Now

SBIR Proposal Lab seeks to help entrepreneurs seeking seed funding from the U.S. government

JHU startup PathoVax raises $2.75M, grows team

How the BioTechnical Institute of Maryland prepares Baltimore residents to work at local labs

SPONSORED

Baltimore

SmartLogic propels digital transformation aboard Baltimore Water Taxi

Annapolis Junction, MD

Asymmetrik

FULL-STACK DEVELOPER

Apply Now
Annapolis Junction, MD

Asymmetrik

SOFTWARE ENGINEER

Apply Now
Annapolis Junction, MD

Asymmetrik

FRONT-END DEVELOPER

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!